Marker Therapeutics, Inc.

Monthly Archives: October 2015

TapImmune to Present at Aegis Capital 2015 Growth Conference in Las Vegas on October 9, 2015

…JACKSONVILLE, Florida, October 7, 2015 /PRNewswire/ –

TapImmune, Inc. (TPIV), a clinical-stage immunotherapy company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, will be featured as a presenting company at the Aegis Capital Corp. 2015 Growth Conference, at the Encore Wynn Hotel in Las Vegas, Nevada which takes place October 7-9, 2015.

Read More